TrumpRx adds medicines from AbbVie, Genentech

TrumpRx, a pharmaceutical initiative, is reportedly expanding its portfolio by incorporating medicines from major pharmaceutical companies AbbVie and Roche's Genentech. This expansion suggests an effort to broaden access to a wider range of treatments under the TrumpRx umbrella. The inclusion of products from these established pharmaceutical giants could significantly enhance the offerings and reach of TrumpRx within the healthcare landscape.